These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6815987)

  • 1. [101 cases of lepromatous leprosy under observation without treatment after stable negativation. Evaluation 20 years later].
    Mugnier P; Rollier M; Rollier R
    Acta Leprol; 1982; (86-87):185-8. PubMed ID: 6815987
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation and relapse in bacterio-negative cases of leprosy under sulphone therapy: a 4 1/2 years follow-up.
    Neelan PN
    Lepr India; 1976 Oct; 48(4 Suppl):661-7. PubMed ID: 1026801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate and time distribution of relapses in multibacillary leprosy.
    Kurz XM; Declercq EE; Vellut CM
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):599-606. PubMed ID: 2778367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of secondary dapsone resistance in Gudiyattam Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 1. Preliminary report.
    Balraj V; Jesudasan K; Chacko CJ; Christian M; Taylor PM; Fritschi EP; Job CK
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):397-401. PubMed ID: 7193654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy.
    Waters MF; Pettit JH
    Int J Lepr; 1965; 33(3):280-96. PubMed ID: 5322767
    [No Abstract]   [Full Text] [Related]  

  • 7. Lepromatous leprosy.
    Fields JP; Hadley TP
    Arch Dermatol; 1969 Nov; 100(5):648. PubMed ID: 5350425
    [No Abstract]   [Full Text] [Related]  

  • 8. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive episodes in borderline lepromatous leprosy--a case report.
    Acharya PV; Gupta OP; Nigam SP; Agrawal RV
    Lepr India; 1976 Jul; 48(3):311-3. PubMed ID: 1022972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 11. Are defaulters with paucibacillary leprosy a problem?
    Jesudasan K; Bradley D; Christian M
    Indian J Lepr; 1985; 57(2):354-9. PubMed ID: 4078362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria, leprosy and dapsone.
    Saha K; Kapoor L; Arora VM; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):501-4. PubMed ID: 15115119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of long-acting sulphonamide R.O. 4-4393 (fanasil) in treatment of cases of lepromatous leprosy with repeated E.N.L.
    Ekambaram V; Venkatachari S
    Lepr India; 1976 Jan; 48(1):24-30. PubMed ID: 1022953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dapsone on blood lactic and pyruvic acids in leprosy.
    Sinha SN; Gupta SC; Bajaj AK; Srivastava NP; Mehrotra TN
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):468-70. PubMed ID: 6892022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dimorphous leprosy].
    Esca SA; Zelger J
    Hautarzt; 1984 Jun; 35(6):298-302. PubMed ID: 6469634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of a trial of dapsone vs placebo in lepromatous leprosy.
    Levy L; Murray LP
    Int J Lepr Other Mycobact Dis; 1967; 35(3):393-4. PubMed ID: 4917111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.